KAVIGALE
As listed in the register: KAVIGALE 300 MG SOLUCION INYECTABLE Y PARA PERFUSION
300 mg · solución inyectable y para perfusión
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Sipavibart
- Made by
- Astrazeneca Ab
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands1 matching products
Details
| Made by | Astrazeneca Ab |
|---|---|
| Active substance | Sipavibart |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 300 mg |
| Form | solución inyectable y para perfusión |
| Classification | J06BD09 · Antibiotics, antivirals and antifungals taken into the body |
| Route | vía intramuscular, vía intravenosa |
| Marketed | No — authorised but not currently marketed, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Name in the register | KAVIGALE 300 MG SOLUCION INYECTABLE Y PARA PERFUSION |
| Nº Registro | 1241900001 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.